Position in IMTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$163,176
-$9,045 QoQ
Shares Held
16,583
+1.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $203,614,751 across 74 Biotechnology names. IMTX ranks #67 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
100,386 | $44,826,363 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,909 | $33,153,208 | |
| 3 | INSM |
INSMED Inc
|
80,021 | $13,085,033 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,114 | $12,279,909 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
91,463 | $5,734,729 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
68,749 | $4,443,247 | |
| 7 | INCY |
Incyte Corp
|
44,622 | $4,199,821 | |
| 8 | EXEL |
Exelixis, Inc.
|
91,477 | $3,923,448 |
All Filings in IMTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $163,176 | 16,583 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $172,221 | 16,402 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $138,688 | 16,278 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $89,076 | 16,557 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $70,644 | 15,664 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $101,033 | 14,210 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||